St. John's Wort (Hypericum perforatum): Clinical effects on depression and other conditions

Alternative Medicine Review

Volumn 3, Issue 1, 1998, Pages 18-26

  Miller, Alan L ^a,b  

^a Thorne Research Incorporated   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; PERYLENE; PLANT EXTRACT; QUERCETIN; XANTHENE DERIVATIVE;

DEPRESSION; HUMAN; HYPERICUM; MEDICINAL PLANT; REVIEW;

DEPRESSION; DEPRESSIVE DISORDER; HUMANS; HYPERICUM; PERYLENE; PLANT EXTRACTS; PLANTS, MEDICINAL; QUERCETIN; XANTHENES;

EID: 0031993961     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Upton R. St. John's Wort Monograph. Herbalgram #40. American Herbal Pharmacopoeia. Summer 1997:3-38.
2. Snow JM. Hypericum perforatum L. (Hyperiaceae). Protocol J Bot Med 1996;2:16-21.
3. Müller WE, Kasper S. Editorial. Pharmacopsychiat 1997;30:71.
4. National Institute of Mental Health website. http://www.nimh.gov.
5. Wheatley D. LI 160, an extract of St. John's Wort versus amitriptyline in mildly to moderately depressed outpatients-a controlled 6-week clinical trial. Pharmacopsychiat 1997;30:S77-S80.
6. Vorbach EU, Arnoldt KH, Hübner WD. Efficacy and tolerability of St. John's Wort extract LI160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiat 1997;30:S81-S85.
7. Hyperici herba. In: Wichtl M, Bisset NG, eds. Herbal Drugs and Phytopharmaceuticals, A Handbook For Practice on a Scientific Basis. Stuttgart, Germany: Medpharm Scientific Publishers; 1994:273-275.
8. Wagner H, Bladt S. Pharmaceutical quality of Hypericum extracts. J Geriatr Psychiatry Neurol 1994;7:S65-S68.
9. Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmcopsychiat 1997;30:S129-S134.
10. Suzuki O, Katsumata Y, Chari M, et al. Inhibition of type A and type B monoamine oxidase by naturally occurring xanthones. Planta Med 1981;42:17-21.
11. Suzuki O, Katsumata Y, Oya M, et al. Inhibition of monoamine oxidase by hypericin. Planta Med 1984;50:272-274.
12. Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr PsychiatÚy Neurol 1994;7:S57-S59.
13. Thiede HM, Walper A. Inhibition of MAO and COMT by Hypericum extracts and Hypericin. J Geriatr Psychiatry Neurol 1994;7:S54-S56.
14. Müller WEG, Rolli M, Schäfer, Hafner U. Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiat 1997;30:S102-S107.
15. Perovic S, Müller WEG. Pharmacological profile of Hypericum extract. Arzneim-Forsch 1995;45:1145-1148.
16. Müller WEG, Rossol R. Effects of Hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994;7:S63-S64.
17. Baureithel KH, Buter KB, Engesser A, et al. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharm Acta Helv 1997;72:153-157.
18. Cott JM. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiat 1997;30:S108-S112.
19. Holsboer F, Lauer CJ, Schreiber W, Krieg JC. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 1995;62:340-347.
20. Peeters BW, Broekkamp CL. Involvement of corticosteroids in the processing of stressful life-events. A possible implication for the development of depression. J Steroid Biochem Mol Biol 1994;49:417-427.
21. Amsterdam JD, Maislin FG, Gold P, Winokur A. The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness. Psychonenroendocrinology 1989;14:43-62.
22. van Praag HM. Faulty cortisol/serotonin interplay. Psychopathological and biological characterization of a new, hypothetical depression subtype (SeCA depression). Psychiatry Res 1996;65:143-157.
23. Thiele B, Brink I, Ploch M. Modulation of cytokine expression by Hypericum extract. J Geriatr Psychiatry Neurol 1994;7:S60-S62.
24. Linde K, Ramirez G, Mulrow C, et al. St. John's Wort for depression-an overview and meta-analysis of randomised clinical trials. Br Med J 1996;313:253-261.
25. Sommer H, Harrer G. Placebo-controlled double blind study examining the effectiveness of an Hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol 1994;7:S9-S11.
26. Hänsgen KD, Vesper J, Ploch M. Multicenter double-blind study examining the antidepressant effectiveness of the Hypericum extract LI 160. J Geriatr Psychiatry Neurol 1994;7:S15-S18.
27. Vorbach EU, Hübner WD, Arnoldt KH. Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine: Randomized double-blind study with 135 outpatients. J Geriatr Psychiatry Neurol 1994;7:S19-S23.